ANSWER-HF RCT in 190 patients with Chagas cardiomyopathy and HFrEF: sacubitril-valsartan vs enalapril did not significantly improve LVEF at 6 months (+2.1% vs +1.2%; P=0.36). Secondary: NT-proBNP was lower and win ratio favoured sacubitril-valsartan (1.80).
RCTn = 190
Madrini et al. Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized Trial